tiprankstipranks

Novartis Venture Fund (NVF) Investment Portfolio

Novartis Venture Fund (NVF) is the corporate venture capital arm of Novartis AG that makes strategic and financial investments in private life sciences and healthcare companies. NVF invests globally across therapeutics, platform technologies, diagnostics, medtech and digital health at early-to-growth stages and frequently participates in syndicates alongside other investors.

Companies Invested In

Company Name
Sector
Investment Round Value
Funding Round
Announcement Date
PC:ARTIOArtios Pharma Limited
Healthcare, Biotechnology & Medical Devices
$115.00M
Series D
Nov 17, 2025
PC:EPIBIEpiBiologics
Healthcare, Biotechnology & Medical Devices
$107.00M
Series B
Jan 08, 2026
PC:EPSILEpsilogen
Healthcare, Biotechnology & Medical Devices
$16.40M
Investment
Nov 19, 2025
PC:FORXTFoRx Therapeutics
Healthcare, Biotechnology & Medical Devices
$50.00M
Series A
Dec 18, 2025
PC:LOQUSLoQus23 Therapeutics Ltd
Healthcare, Biotechnology & Medical Devices
$35.00M
Series A
Aug 14, 2025
PC:NRGTHNRG Therapeutics
Healthcare, Biotechnology & Medical Devices
$67.00M
Series B
Sep 08, 2025
PC:PRO35Protego Biopharma
Healthcare, Biotechnology & Medical Devices
$130.00M
Series B
Dec 01, 2025
PC:SPLICSpliceBio
Healthcare, Biotechnology & Medical Devices
$135.00M
Series B
Jun 11, 2025